Gradient Investments’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,800
| Closed | -$6.31K | – | 1461 |
|
|
2023
Q4 | $6.31K | Hold |
3,800
| – | – | ﹤0.01% | 936 |
|
|
2023
Q3 | $7.3K | Hold |
3,800
| – | – | ﹤0.01% | 868 |
|
|
2023
Q2 | $5.47K | Hold |
3,800
| – | – | ﹤0.01% | 938 |
|
|
2023
Q1 | $7.98K | Hold |
3,800
| – | – | ﹤0.01% | 856 |
|
|
2022
Q4 | $4.29K | Hold |
3,800
| – | – | ﹤0.01% | 958 |
|
|
2022
Q3 | $6K | Hold |
3,800
| – | – | ﹤0.01% | 909 |
|
|
2022
Q2 | $5K | Hold |
3,800
| – | – | ﹤0.01% | 891 |
|
|
2022
Q1 | $6K | Hold |
3,800
| – | – | ﹤0.01% | 860 |
|
|
2021
Q4 | $8K | Hold |
3,800
| – | – | ﹤0.01% | 843 |
|
|
2021
Q3 | $15K | Hold |
3,800
| – | – | ﹤0.01% | 688 |
|
|
2021
Q2 | $12K | Hold |
3,800
| – | – | ﹤0.01% | 727 |
|
|
2021
Q1 | $8K | Hold |
3,800
| – | – | ﹤0.01% | 804 |
|
|
2020
Q4 | $10K | Hold |
3,800
| – | – | ﹤0.01% | 694 |
|
|
2020
Q3 | $10K | Hold |
3,800
| – | – | ﹤0.01% | 697 |
|
|
2020
Q2 | $12K | Hold |
3,800
| – | – | ﹤0.01% | 614 |
|
|
2020
Q1 | $7K | Hold |
3,800
| – | – | ﹤0.01% | 715 |
|
|
2019
Q4 | $11K | Buy |
+3,800
| New | +$11K | ﹤0.01% | 671 |
|